Jennison Global Healthcare Master Fund, Ltd. - Net Worth and Insider Trading

Jennison Global Healthcare Master Fund, Ltd. Net Worth

The estimated net worth of Jennison Global Healthcare Master Fund, Ltd. is at least $424,709 dollars as of 2024-11-13. Jennison Global Healthcare Master Fund, Ltd. is the 10% Owner of Alpine Immune Sciences Inc and owns about 6,537 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $424,709. Details can be seen in Jennison Global Healthcare Master Fund, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennison Global Healthcare Master Fund, Ltd. has not made any transactions after 2015-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jennison Global Healthcare Master Fund, Ltd.

To

Jennison Global Healthcare Master Fund, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennison Global Healthcare Master Fund, Ltd. owns 1 companies in total, including Alpine Immune Sciences Inc (ALPN) .

Click here to see the complete history of Jennison Global Healthcare Master Fund, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Jennison Global Healthcare Master Fund, Ltd.

Ticker Comapny Transaction Date Type of Owner
ALPN Alpine Immune Sciences Inc 2015-06-17 10 percent owner

Jennison Global Healthcare Master Fund, Ltd. Latest Holdings Summary

Jennison Global Healthcare Master Fund, Ltd. currently owns a total of 1 stock. Jennison Global Healthcare Master Fund, Ltd. owns 6,537 shares of Alpine Immune Sciences Inc (ALPN) as of June 17, 2015, with a value of $424,709.

Latest Holdings of Jennison Global Healthcare Master Fund, Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALPN Alpine Immune Sciences Inc 2015-06-17 6,537 64.97 424,709

Holding Weightings of Jennison Global Healthcare Master Fund, Ltd.


Jennison Global Healthcare Master Fund, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennison Global Healthcare Master Fund, Ltd. has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 6,537 shares on June 17, 2015, which cost Jennison Global Healthcare Master Fund, Ltd. around $366,086.

Insider Trading History of Jennison Global Healthcare Master Fund, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennison Global Healthcare Master Fund, Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Jennison Global Healthcare Master Fund, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennison Global Healthcare Master Fund, Ltd. is 20.71%. GuruFocus also compares Jennison Global Healthcare Master Fund, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennison Global Healthcare Master Fund, Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennison Global Healthcare Master Fund, Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennison Global Healthcare Master Fund, Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.41 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 26.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Jennison Global Healthcare Master Fund, Ltd. Ownership Network

Ownership Network List of Jennison Global Healthcare Master Fund, Ltd.

No Data

Ownership Network Relation of Jennison Global Healthcare Master Fund, Ltd.

Insider Network Chart

Jennison Global Healthcare Master Fund, Ltd. Owned Company Details

What does Alpine Immune Sciences Inc do?

Who are the key executives at Alpine Immune Sciences Inc?

Jennison Global Healthcare Master Fund, Ltd. is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .

Alpine Immune Sciences Inc (ALPN) Insider Trades Summary

Over the past 18 months, Jennison Global Healthcare Master Fund, Ltd. made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alpine Immune Sciences Inc Insider Transactions

No Available Data

Jennison Global Healthcare Master Fund, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Jennison Global Healthcare Master Fund, Ltd.. You might contact Jennison Global Healthcare Master Fund, Ltd. via mailing address: C/o Jennison Associates Llc, 466 Lexington Avenue, New York Ny 10017.